Anat O Stemmer-Rachamimov (Anat Stemmer-Rachamimov)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Age Related Macular Degeneration

Gold Nanoparticles

Top Venues

Acta neuropathologica

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, Justin T Jordan, Joseph F Rd Rizzo
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1). Acta neuropathologica 147 (1) (2024)
Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, Justin T Jordan, Joseph F Rd Rizzo
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1). Acta neuropathologica 147 (1) (2024)
Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, Justin T Jordan, Joseph F Rd Rizzo
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1). Acta neuropathologica 147 (1) (2024)
Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, Justin T Jordan, Joseph F Rd Rizzo
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1). Acta neuropathologica 147 (1) (2024)
Pike-See Cheah, Shilpa Prabhakar, David Yellen, Roberta L Beauchamp, Xuan Zhang, Shingo Kasamatsu, Roderick T Bronson, Elizabeth A Thiele, David J Kwiatkowski, Anat O Stemmer-Rachamimov, Bence György, King-Hwa Ling, Masao Kaneki, Bakhos A Tannous, Vijaya Ramesh, Casey A Maguire, Xandra O Breakefield
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Science advances 7 (2) (2021)
Limeng Wu, Sasa Vasilijic, Yao Sun, Jie Chen, Lukas David Landegger, Yanling Zhang, Wenjianlong Zhou, Jun Ren, Samuel Early, Zhenzhen Yin, William W Ho, Na Zhang, Xing Gao, Grace Y Lee, Meenal Datta, Jessica E Sagers, Alyssa Brown, Alona Muzikansky, Anat O Stemmer-Rachamimov, Luo Zhang, Scott R Plotkin, Rakesh K Jain, Konstantina M Stankovic, Lei Xu
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models. Science translational medicine 13 (602) (2021)